Nav: Home

'This enormous burden': Controlling cervical cancer in Latin America

October 08, 2015

The latest Special Issue from ecancermedicalscience collects four new research articles on the topic of cervical cancer prevention in Latin America.

Cervical cancer is an "enormous burden" for Latin American society, and the third leading cause of cancer deaths among women in the region, say Guest Editors Dr María Correnti and Dr María Eugenia Cavazza of the Central University of Venezuela, Caracas, Venezuela.

"In contrast to other types of cancer, cervical cancer is a preventable and curable disease if it is diagnosed and treated early," say Drs Correnti and Cavazza in an accompanying editorial.

"But the absence of an effective prevention strategy leads to delayed diagnosis, and turns it into one of the leading causes of death among young women."

In 2012, the Pan American Health Organization estimated there were 36,000 deaths due to cervical cancer in the Americas - and 80% of these deaths occurred in Latin America and the Caribbean.

Expert authors highlight three key research areas in the collection - epidemiology, prevention, and HPV infection. The topic of cervical cancer prevention is addressed from two vital angles - one article examines the types and impact of prevention programs in Latin America, while the second highlights the increasing role of elearning in cancer prevention.

From Dr Luis Capote Negrin of the Oncology Program of the Spanish Ministry of Health comes a piece on the epidemiology of cervical cancer in Latin America, analysing the patterns - and impacts - of the disease through Globocan reports.

"It is important to learn from the experiences of other countries to improve the health of women not only as a health goal, but as an ethical imperative," says Dr Ileana Quirós Rojas of Caja Costarricense de Seguro Social, San José, Costa Rica. Her article describes a grassroots system of cervical cancer prevention in Costa Rica, combining social, medical and psychological factors from improving screening procedures to helping women access healthcare.

An alternative vision is offered by researchers at the Catalan Institute of Oncology, Spain led by Dr Assumpta Company. Their article describes a programme of prevention through elearning, creating new tools to educate healthcare professionals.

"Clearly the promotion and use of these tools, particularly in Latin America, would represent an important achievement in the development of national plans for the control of cervical cancer," comment Drs Correnti and Cavazza.

Researchers led by Dr Luis Téllez of the University of the Andes, Venezuela present an article on the nature of human papillomavirus (HPV) infection in the Venezuelan population. Their findings show that infections of this virus are slightly more prevalent in Venezuela than in European countries, and suggest that intervention will be a key method of prevention. As HPV infection is one of the most common causes of cervical cancer, this paper is a call to action for Latin American countries.

The articles are available in Spanish and English, and are freely available for all to read in ecancer's open-access journal.

We hope to enable readers around the world to take full advantage of this information - while the articles themselves are focused around Latin America, their findings will be of interest worldwide.
Read the articles here:

Capote Negrin Luis G (2015) Epidemiology of cervical cancer in Latin America ecancer 9 577

Quirós Rojas Ileana (2015) The cervical cancer prevention programme in Costa Rica ecancer 9 578

Téllez Luis, Mendoza José Andrés, Vielma Silvana, Noguera María-Eugenia, Callejas Diana, Cavazza María and Correnti Maria (2015) Persistent infection with high-risk human papilloma viruses: cohort study, Mérida, Venezuelaecancer 9 579

Company Assumpta, Montserrat Mireia, Bosch Francesc X and de Sanjosé Silvia (2015) Training in the prevention of cervical cancer: advantages of e-learning ecancer 9 580


Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".